|
Full steam ahead?
Jun 3rd 2004
From The Economist print edition
Superconductors
are starting to become useful
A WAG once said of Brazil
that it is tomorrow's country, and always will be.
Superconductivity frequently suffers similar jibes. On the
face of things, a technique that allows electricity to be
transmitted without resistance should be ubiquitous. But the
obstacles have proved insurmountable for all but niche
applications, such as medical imaging.
Three things stand in the
way of the wider use of superconductors. First, they need to
be cooled well below room temperature. Second, those that
need the least cooling are the most difficult to work with.
Third, the passage of an electric current creates magnetism,
and magnetism tends to destroy superconductivity.
But these obstacles are
being overcome. As a result, superconductivity is starting
to appear in applications as diverse as telecoms and
electric motors. There is even talk of reaching
superconductor nirvana: using them for controlling and
transmitting large amounts of electrical power.
The future's taped
Superconductor
Technologies, a company based in Santa Barbara, California,
is building superconducting filters for mobile-phone base
stations. In common with all the other putative mass-market
applications of superconductivity, the materials in question
are so-called high-temperature superconductors (HTSs).
High-temperature is a relative concept. These materials need
to be cooled with liquid nitrogen (a mere -196°C). But that
is cheap compared with the liquid helium (-269°C) used to
cool traditional superconductors, such as those employed in
medical imaging. There is, however, a price to pay. HTSs are
ceramics, and thus much harder to shape and work than
traditional superconductors, which are metals. This
difficulty is an especially important factor when what is
required is something that will do the same job as a
traditional wire.
Superconducting
Technologies' devices, though, are not wires. They are chips
with superconducting surfaces. No flexion is involved, so
using rigid ceramics is not a problem. The superconductor's
lack of resistance allows the firm to build filters that can
chop a signal into much narrower frequency bands than a
traditional filter. This, in turn, translates into improved
performance. In a recent test on a commercial network, using
superconducting filters increased that network's capacity by
half.
Mobile-phone networks are
an important market, but a specialised one. The hope in the
industry is that HTSs will be taken up in more traditional,
but bigger electrical-engineering applications. This is the
sort of thing that American Superconductor, a firm based in
Westborough, Massachusetts, is working on.
American Superconductor
believes it has cracked the most difficult fabrication
problem of HTSs, turning them into the equivalent of wire.
Ceramics cannot be drawn in the way that metal is. Instead,
American Superconductors and its rivals powder the stuff and
pack it into silver tubes. The tubes, being metallic, can be
drawn. They can also be plaited together to form cables,
heated to improve the contact between the superconducting
grains, and rolled flat. The result is flexible tapes that
can be used in a similar way to wires.
One application of these
tapes is in electric motors. And, as is often the way with
new technologies in America, the government has conveniently
created a market opportunity. It did so by announcing four
years ago its intention to convert the country's navy to a
fleet powered by electric motors.
Accordingly, American
Superconductor has been using its tape to build
superconducting motors. The first, a small one producing 5
megawatts, was delivered to the navy a year ago, and has
completed its tests successfully. As a result, a 36.5
megawatt motor will be delivered next year. This motor is
easily big enough to propel a destroyer (it is just a tad
less powerful than were the engines of the Titanic).
But, according to Greg Yurek, American Superconductor's
boss, it will be a third of the weight of its conventional
alternative.
American Superconductor is
also starting to infiltrate another area of heavy electrical
engineering: power transmission. The first application the
firm has in mind is a niche in this market, but it is an
important one: stabilising the grid in order to prevent
power failures. In January, the firm installed a prototype
“synchronous condenser” designed to provide this stability
to an electrical sub-station in Tennessee. Large-scale
electricity transmission usually uses alternating current,
in which both current and voltage oscillate. Crashes occur
when the two get out of sync. The condenser's job is to stop
this happening.
American Superconductor and
its competitors are also engaged in a race to make
superconducting tape that could be used to carry power on
the grid itself. The challenge here is twofold. The first is
to create tapes that can support large currents undisturbed
by the magnetic fields those currents create. The second is
to scale up the processes by which the tapes are made, to
allow mass production.
The current record-holder
for current, as it were, is SuperPower, a firm based in
Schenectady, New York. In March, it transmitted 120 amps
over a distance of 50 metres—three times better than the
best previous result. The trick in this tape—and other
so-called “second-generation” tapes—is that a thin layer of
the superconducting ceramic is sandwiched between two layers
of metal. Such a thin layer alters the current flow in a way
that reduces the current's susceptibility to magnetic
interference. It also results in a tape that costs a third
to a fifth as much to make.
SuperPower is now scaling
up its production capacity. By next year it should be able
to make cables a third of a kilometre long. It plans to use
one of these to connect two sub-stations in Albany, New
York. Shorter, experimental segments have already been tried
elsewhere, but the significance of the Albany project is
that it will be using superconducting cables in a completely
commercial environment. Then, perhaps, superconductivity's
tomorrow will truly have arrived.
Top
TIMES NEWS NETWORK
[ MONDAY, JUNE 07, 2004 12:51:26 AM ]
WASHINGTON:
An Indian scientist in Massachusetts is among five winners
of the Jefferson Science Fellowships awarded by the US State
Department.
Dr Kalidas Shetty, an associate professor
of food biotechnology at the University of Massachusetts at
Amherst, and four others attended a ceremony at the State
Department recently, where they were greeted by Secretary of
State Colin Powell. “Over the coming year, these five
individuals will be our scientific advisers and educators.
They will bring fresh ideas and new perspectives to
America's foreign policy,” he said.
The other four Jefferson Science Fellows
are: Dr. Julian Adams of Michigan University, Dr. Bruce
Averill of Toledo University; Dr. Melba Crawford of the
Texas University at Austin; and Dr. David Eston of
California. At the ceremony, Powell said that the Jefferson
program gives the State Department the opportunity to
benefit from the counsel and experience of featured academic
scientists. Shetty, who has a Ph.D. from the University of
Idaho, holds several patents.
Top
Project
promotes domestic intellectual property rights
Qin Chuan
2004-05-31 06:38
Chinese pharmaceutical companies are making progress in
terms of intellectual property rights protection.
At least four new medicines developed
under a key national project have received approval from the
State Food and Drug Administration since 2002, when the
project was launched to encourage innovation of new
medicines and the modernization of the traditional Chinese
medicine industry.
Intellectual property rights of the four
medicines are owned by Chinese researchers and
pharmaceutical companies, according to Yang Zhe, head of the
biomedicine division of the Ministry of Science and
Technology. Meanwhile, more than 20 new medicines have
entered the stage of clinical experiments, Yang said.
Xiao Shiying, an official with the
administrative centre for Agenda 21, China's centre for UN's
global development project, said nearly 60 traditional
Chinese medicines are being developed under the project.
Currently few of the medicines have been
finished, Xiao said, but some are expected to be approved by
the State Food and Drug Administration next year.
"The awareness of intellectual property
right protection in the traditional Chinese medicine
industry is far from enough," said Cai Zhongde, with the
institute of traditional Chinese medicines at the Chinese
Academy of Traditional Chinese Medicine.
Meanwhile, the technological strength of
Chinese companies and research institutes is weak and
therefore innovation is difficult to achieve, he said.
Although the number of patented
traditional Chinese medicines has risen in recent years, the
number of completely innovated ones remains relatively
small, Cai said.
Yang said China began to pay more
attention to the development of patented medicines in the
Ninth Five-Year Plan (1996-2000). But it was not until the
project was launched in 2002 that such an attempt was
strengthened.
The project was launched by the Ministry
of Science and Technology as one of the key national
scientific and technological projects during the 10th
Five-Year Plan (2001-05).
It is expected that the project will help
transform the Chinese pharmaceutical industry from a
"copier" to an "innovator."
The ministry hopes to see a group of
compound synthetic medicines, herbal medicines and
bio-engineered drugs developed, whose intellectual property
rights will be owned by Chinese companies or researchers.
Statistics from GlaxoSmithKline (GSK), a
leading pharmaceutical company, show China is the seventh
largest pharmaceutical market in the world with a value of
US$6.8 billion from drugs in 2002.
It is estimated China's medical market
will be US$14 billion by 2006 and US$24 billion by 2010.
However, China's own pharmaceutical
industry is weak in the research and development of new
products because it has long depended on replicating
imported drugs, insiders say.
At present, Chinese companies put only 2
per cent of their sales income into development, compared
with more than 20 per cent by leading pharmaceutical
companies in the world.
More than 6,700 drug companies produce
about 1,300 types of synthetic medicines in China, 97 per
cent of which, however, are generic medicines.
With its entry into the World Trade
Organization, China has pledged its commitment to greater
protection of intellectual property rights on medicines, and
the domestic pharmaceutical industry is expected to face
more challenges.
(China Daily 05/31/2004 page5)
Top
PHARMACEUTICALS
Chemical & Engineering News
May 31, 2004, Volume 82, Number 22
p. 6
ABBOTT DEFENDS NORVIR PRICE HIKE
Consumer group seeks U.S. intervention over 400% increase
for AIDS drug
RICK MULLIN
Abbott Laboratories defended the recent 400% price
increase for its AIDS drug
Norvir (ritonavir) before a government panel last week
in an effort to forestall the issuance of licenses for
generic versions of the drug under the 1980 Bayh-Dole Act.
Essential Inventions, a consumer advocacy group, has
petitioned the Department of Health & Human Services to
invoke the law, which ensures public access to
government-funded inventions. Abbott had received a $3.5
million
NIH grant for the development of Norvir. The drug, with
2003 sales of $95 million, is scheduled to come off patent
in 2014.
Citing the expense of drug discovery and Norvir’s low cost
compared with other treatments, Abbott upped the price of a
100-mg dose from $1.71 per day to $8.57 in December,
sparking protest from AIDS activists. Jeffrey M. Leiden,
president of Abbott’s pharmaceutical products group, told an
NIH committee last week that the price hike does not affect
government programs such as Medicaid and that uninsured
patients can receive Norvir for free.
Leiden said Bayh-Dole is only applicable to inventions that
have not been commercialized, arguing that the law “was
never intended to be a mechanism to determine prices.” He
noted that the federal grant covered less than 1% of
Norvir’s development cost of more than $300 million.
Former senator Birch Bayh, an author of Bayh-Dole, supported
Leiden’s view before the committee, specifically cautioning
against the use of the law to control drug prices.
Essential Inventions founder James Love argued that Abbott
is not making Norvir available to the public on “reasonable
terms” as required under Bayh-Dole. “The facts in the Abbott
case are so extreme that a ‘sky is the limit’ or ‘anything
goes’ precedent will have been set,” he said.
Top
NFC generates cumulative surplus of Rs 631.7 cr
Hyderabad , June 19
THE Nuclear Fuel Complex (NFC), a
Department of Atomic Energy (DAE) undertaking, has generated
a net cumulative surplus of Rs 631.7 crore for the
exchequer.
For the financial year ended March 31,
NFC's revenues stood at Rs 710.35 crore (Rs 776.58 crore) as
against an expenditure of Rs 447.94 crore (Rs 589.23 crore).
The annual revenue receipts were in the
range of Rs 624 crore to Rs 823 crore, far exceeding annual
expenditures that were in the range of Rs 399 crore to Rs
589 crore. A lesser plant load factor of reactors resulted
in a dip in revenues recently.
Giving these details at a press
conference, Dr C. Ganguly, Chairman and Chief Executive of
NFC, said the NFC has embarked on a major expansion to meet
the increasing demands from the nuclear power sector. It
supplies fuel bundles and core components for nuclear
reactors.
While the 1,200-acre Palayakkayal (near
Tuticorin) Zirconium sponge production unit will be
completed in three years, NFC's third unit will come up at
Jaduguda in Jharkand State at an estimated cost of Rs 286
crore, Dr Ganguly said.
The expansion was part of NFC's plan to
meet the targets set by the department to achieve 20,000 MW
power generation by 2020.
He said the NFC had crossed a major
milestone of manufacturing three lakh fuel bundles, made of
natural uranium oxide pellets and enwrapped in zircaloy
pipes, for nuclear reactors in the country.
While the 19-element fuel bundle (for 220
MW units) carries 15 kg of high-density uranium oxide
pellets that can generate 6.40 lakh units of electricity,
the 37-element bundle (for 540 MW units) carries 22 kg of
pellets capable of producing 9.26 lakh units of electricity.
"It took 20 years to produce one lakh
fuel bundles, while it took just seven more years to reach
the two-lakh landmark and three years for reaching the
three-lakh mark," Dr Ganguly said.
Power of nuclear energy: Strongly
advocating for nuclear energy, Dr Ganguly said nuclear
option ensured affordable, sustainable power supply. Nuclear
power held good promise keeping in view the increased
preference for non-carbon based energy sources.
"The deposits, if fully utilised, could
result in an installed capacity of 350 GW providing power
for 1,000 years," Dr Ganguly said.
"There are 14 basins that comprise
nuclear resources. We tapped only two so far," he said.
Strongly recommending for taking up the
Nalgonda Uranium project (in Cuddapah basin), he said it
suited well because of better logistic facilities.
Meanwhile, Dr Ganguly has been appointed
as a Director of Nuclear Fuel Cycle at the International
Atomic Energy Agency. He is expected to take up the new
assignment in August.
Mr R. Kalidas, a Deputy Chief Executive
with the Complex, will replace Dr Ganguly. At present, Mr
Kalidas is the in-charge of NFC's Tubes Group.
Top
N-power sector may be opened up — Changes to
Atomic Energy Act await Cabinet nod
Business Line,T.S. Subramanian
Chennai , June 21
A TOTAL review of the Atomic Energy Act
is under way to find out areas where modifications are
required to enable private participation, both by Indian or
foreign companies, for the construction of nuclear power
projects in the country, according to Mr S.K. Jain, Chairman
and Managing Director, Nuclear Power Corporation of India
Ltd (NPCIL). The Atomic Energy Act controls nuclear
activities in the country.
Speaking to Business Line , Mr
Jain said, ``As per my understanding and knowledge,
modifications to the Atomic Energy Act have already been
drawn up. They have been reviewed by various ministries and
are ready for consideration by the Union Cabinet.
Subsequently, Parliament will consider these amendments to
the Act.''
``We are hoping that by this year-end the
amendments to the Act will be passed by Parliament paving
the way for joint venture, (even) 100 per cent private
participation in building nuclear power plants in the
country.''
Mr Jain stressed that there would,
however, be ``built-in clauses'' in the Act which would
entail that regulatory aspects connected to sensitive
nuclear material and issues of safety would be ``totally
under the purview of the Department of Atomic Energy (DAE)
and the Atomic Energy Regulatory Board (AERB).''
AERB is the watchdog body that monitors
safety in nuclear power plants in the country. It is in
overall control of safety of nuclear power plants in the
country.
``AERB will be playing the same role from
siting to decommissioning of the private plants. DAE will
have total control over the nuclear material. Whatever
nuclear material is being purchased and used, it will be
under the command of DAE so that they will be effectively
regulated,'' Mr Jain said.
Top
Boeing,
ISRO to build satellite
PTI
[ TUESDAY, JUNE 22, 2004 06:57:52 PM ]
BANGALORE: Boeing and Indian Space
Research Organisation are set to jointly build a two-tonne
satellite for the international market with the American
firm getting the nod from the United States government, key
US and Indian officials indicated on Tuesday.
"Our government recently approved a licence authorising
Boeing Satellite Systems to engage in discussions and share
data with ISRO on the division of responsibilities for
possible joint cooperation in the development and marketing
of communication satellites," US under secretary of Commerce
Kenneth I Juster said.
Juster stated this during the course of his speech to the
India-United States Conference on space science,
applications and commerce, here.
When reporters later sought details, he reiterated the
statement, saying he was doing so with the consent of both
parties (Boeing and ISRO) but declined to elaborate pointing
out that US Government did not comment on individual cases
|